Last year, we were extremely pleased that the majority of our business came from clients with whom we have worked previously – a testament to our clients’ satisfaction and trust.

“A highly intelligent group, yet friendly and accessible. The whole team is professional and innovative and they produce excellent work. You can trust that they will do the job that is required, not necessarily just the job you tell them to do, to high standards, and as a business partner not just a supplier. Personal attention from the relevant people makes working with Black Swan not only rewarding but a pleasure.”

Global Pharmaceutical Company, Director of Business Intelligence

“We were very impressed with the work conducted by Black Swan for us and it has set a new standard of asset valuation for our investors”

University of Manchester Intellectual Property, Venture Manager, Life Sciences and Medical & Human Sciences

“The Black Swan Analysis team produced high quality models for several health economic projects. Their work is very methodical and based on a thorough analysis and interpretation of the available data. One of their real skills lies in making complex models and modelling concepts easy to grasp and to use. I would highly recommend the BSA team both in terms of their outputs and also the excellent working relationships they foster with clients.”

Amgen, Senior Health Economist

“Black Swan helped our company to not only map out the patient journey, but identified leverage points for change. It was a logical user-friendly model interface which utilised all available data sources. The success of the work is evident as 2 years post completion; it remains at the heart of our strategic thinking as well as our operational planning.”

Gilead Sciences, International Commercial Strategy

“I was really impressed by the work that Black Swan had produced for us. They quickly understood the complexity of the opportunity our product could deliver, carried out a thorough analysis and provided a clear valuation that put us in a strong position with prospective investors and shareholders. I would highly recommend them!”

Avid Radiopharmaceuticals, Vice-President Sales & Marketing